Stocks / Stock overview
Solstice Advanced Materials Inc. (SOLS)
$63.53+12.76%Aft $63.90 (+0.58%)Market cap $10.09B
NasdaqGS · Price as of · Nasdaq Real Time Price
Stock Scorer
Scoring…
Analyst consensus
$80.43
- Analysts7
- Implied upside+26.6%
- Target range$70.00 to $95.00
Analyst estimates are opinions, not forecasts of what the stock will do.
Source: Yahoo Finance consensus, retrieved
Next earnings
before the open
- EPS expected$0.71
- Revenue expected$1.02B +5.1%
- Estimate range$0.68 to $0.72
Consensus of 6 analysts for the quarter ending September 30, 2026. Estimates are what Wall Street expects, not our forecast.
Source: Yahoo Finance earnings calendar
Congress trades
| Date | Member | Action | Amount | |
|---|---|---|---|---|
| 2026-08-11 | Kelly Louise Morrison MN | Sale | $1,001 - $15,000 |
SEC filings
| Form | Filed | Description |
|---|---|---|
| 8-K | August 27, 2026 | FORM 8-K |
| 425 | August 11, 2026 | 425 |
| 4 | August 4, 2026 | FORM 4 |
| 4 | August 3, 2026 | FORM 4 |
| 4 | August 3, 2026 | FORM 4 |
| 4 | August 3, 2026 | FORM 4 |
| 425 | August 3, 2026 | 425 |
| 4 | July 30, 2026 | FORM 4 |
Frequently asked questions
When does SOLS report earnings?
Solstice Advanced Materials Inc. (SOLS) is scheduled to report quarterly results on October 29, 2026, before the open. The 6-analyst consensus is $0.71 per share on revenue of $1.02B for the quarter ending September 30, 2026.
What do analysts expect for SOLS?
7 analysts cover Solstice Advanced Materials Inc. (SOLS). The consensus rating is Buy. The average price target is $80.43, in a range of $70.00 to $95.00.
Are insiders buying or selling SOLS?
We have no qualifying Form 4 insider purchases or sales on record for Solstice Advanced Materials Inc. (SOLS). Sales are only tracked above a dollar threshold, so small routine trades may not appear.
Where can I see SOLS SEC filings?
Recent filings are listed on this page, newest first. The latest is an 8-K filed August 27, 2026.
Data on this page comes from SEC EDGAR, public disclosure feeds and market data providers, and may be delayed or incomplete. Nothing here is investment advice.